- Home
- ACIU vs NRGV Comparison
ACIU vs NRGV Comparison
Compare ACIU & NRGV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- NRGV
- Stock Information
- Founded
- ACIU 2003
- NRGV 2017
- Country
- ACIU Switzerland
- NRGV United States
- Employees
- ACIU N/A
- NRGV N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- NRGV Industrial Machinery/Components
- Sector
- ACIU Health Care
- NRGV Miscellaneous
- Exchange
- ACIU Nasdaq
- NRGV Nasdaq
- Market Cap
- ACIU 189.1M
- NRGV 190.1M
- IPO Year
- ACIU 2016
- NRGV N/A
- Fundamental
- Price
- ACIU $2.02
- NRGV $0.71
- Analyst Decision
- ACIU Strong Buy
- NRGV Buy
- Analyst Count
- ACIU 1
- NRGV 3
- Target Price
- ACIU $12.00
- NRGV $1.58
- AVG Volume (30 Days)
- ACIU 128.8K
- NRGV 2.0M
- Earning Date
- ACIU 08-05-2025
- NRGV 08-05-2025
- Dividend Yield
- ACIU N/A
- NRGV N/A
- EPS Growth
- ACIU N/A
- NRGV N/A
- EPS
- ACIU N/A
- NRGV N/A
- Revenue
- ACIU $32,014,254.00
- NRGV $46,974,000.00
- Revenue This Year
- ACIU N/A
- NRGV $362.17
- Revenue Next Year
- ACIU $533.21
- NRGV $48.19
- P/E Ratio
- ACIU N/A
- NRGV N/A
- Revenue Growth
- ACIU 91.20
- NRGV N/A
- 52 Week Low
- ACIU $1.43
- NRGV $0.60
- 52 Week High
- ACIU $4.26
- NRGV $2.70
- Technical
- Relative Strength Index (RSI)
- ACIU 57.93
- NRGV 38.86
- Support Level
- ACIU $2.01
- NRGV $0.74
- Resistance Level
- ACIU $2.19
- NRGV $0.93
- Average True Range (ATR)
- ACIU 0.14
- NRGV 0.07
- MACD
- ACIU 0.00
- NRGV -0.02
- Stochastic Oscillator
- ACIU 60.75
- NRGV 22.91
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About NRGV Energy Vault Holdings Inc.
Energy Vault Holdings Inc is a grid-scale energy storage company that is driving a faster transition to renewable power by solving the intermittence issues that are inherent to the prevalent sources of renewable energy, solar and wind. Geographical presence in United States, China and Other. Majority of its revenue comes from U.S.